Molecular Pharmacology & Chemistry Program
Chemical biologist Gabriela Chiosis studies the pharmacological modulation of molecular chaperones in transformed systems.
Molecular Pharmacology & Chemistry Program
Samuel Danishefsky investigates the synthesis of antitumor natural products and of fully synthetic carbohydrate-based vaccines.
Molecular Pharmacology & Chemistry Program
Chemist Daniel Heller focuses on biomaterials and nanoscale engineering for molecular sensors and targeted therapeutics.
Human Oncology & Pathogenesis Program
Physician-scientist James Hsieh focuses on the development of novel therapeutics targeting cancer cell proliferation and establishment of a translational kidney cancer program.
Immunology Program
Immunologist Morgan Huse investigates intracellular signaling dynamics in lymphocytes.
Cell Biology Program
Cell biologist Xuejun Jiang studies programmed cell death, molecular mechanisms, and their roles in tumorigenesis.
Molecular Pharmacology & Chemistry Program
Cancer biologist Michael Kharas studies RNA regulators of self-renewal in both normal and leukemic hematopoiesis.
Memorial Hospital Research Laboratories
Radiochemist Jason Lewis develops radiopharmaceuticals for the imaging and therapy of cancer.
Molecular Pharmacology & Chemistry Program
Biochemist Yueming Li studies function and regulation of transmembrane proteases and development of novel protease-based cancer therapies.
Structural Biology Program
Structural biologist Christopher Lima studies the structural biology of post-translational protein modification and RNA processing.
Structural Biology Program
Structural biologist Stephen Long studies the structural biology of ion channels and enzymatic membrane proteins.
Molecular Pharmacology & Chemistry Program
Chemist Minkui Luo develops chemical tools to elucidate protein-posttranslational modification and designs inhibitors for cancer therapies.
Molecular Pharmacology & Chemistry Program
Pharmacologist Gavril Pasternak studies molecular mechanisms of opioid receptor actions, analgesics, and G-protein-coupled receptors.
Structural Biology Program
Structural biologist Dinshaw Patel studies the structural biology of macromolecular recognition, including RNA catalysis, RNA interference, and bypass of DNA damage.
Chair, Structural Biology Program, SKI
Structural Biology Program
Structural Biology Program Chair Nikola Pavletich studies the structural biology of oncogenes and tumor suppressors.
Chair, Molecular Pharmacology & Chemistry Program, SKI
Molecular Pharmacology & Chemistry Program
Molecular Pharmacology and Chemistry Program Chair David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.
Molecular Biology Program
Molecular biologist Stewart Shuman studies mechanisms and structures of the mRNA cap-forming enzymes and the means by which capping is coupled to transcription.
Molecular Pharmacology & Chemistry Program
Chemist Derek Tan studies diversity-oriented synthesis and rational drug design for chemical biology and drug discovery.
Computational Biology Program
Computational biologist Harel Weinstein investigates the structural, dynamic, and integrative determinants of molecular and cellular mechanisms underlying physiological function and pharmacological activity.
